Samsara Bio Capital, LLC Prime Medicine, Inc. Transaction History

Samsara Bio Capital, LLC

  • $326 Million
  • Q4 2024

A detailed history of Samsara Bio Capital, LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 405,228 shares of PRME stock, worth $656,469. This represents 0.36% of its overall portfolio holdings.

Number of Shares
405,228
Previous 540,304 25.0%
Holding current value
$656,469
Previous $2.09 Million 43.4%
% of portfolio
0.36%
Previous 1.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$2.64 - $4.46 $356,600 - $602,438
-135,076 Reduced 25.0%
405,228 $1.18 Million
Q1 2024

May 15, 2024
BUY
$6.35 - $9.39 $444,500 - $657,300
70,000 Added 14.88%
540,304 $3.78 Million
Q1 2023

May 15, 2023
BUY
$11.21 - $21.11 $5.27 Million - $9.93 Million
470,304 New
470,304 $5.78 Million
Q4 2022

Feb 14, 2023
BUY
$15.2 - $21.12 $7.15 Million - $9.93 Million
470,304 New
470,304 $8.74 Million

Others Institutions Holding PRME

# of Institutions
140
Shares Held
58.8M
Call Options Held
52.6K
Put Options Held
173K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $155M
More about PRME
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email